paradigm
rna
viru
biolog
errorpron
genom
replic
due
lack
proofread
postrepl
rna
repair
mechan
decreas
replic
fidel
may
constrain
rna
genom
size
complex
risk
accumul
deleteri
mutat
lead
popul
extinct
genet
divers
allow
viral
popul
adapt
rapidli
select
pressur
mani
mutat
neutral
detriment
viral
fit
research
perform
mani
rna
virus
support
hypothesi
mutat
rate
rna
viru
replicas
evolv
balanc
multipl
characterist
viral
popul
genet
divers
genom
integr
virul
high
lowfidel
variant
describ
mani
rna
virus
infect
anim
includ
coronavirus
cov
murin
hepat
viru
sever
acut
respiratori
syndromeassoci
coronaviru
sarscov
well
footandmouth
diseas
viru
polioviru
chikungunya
viru
influenza
viru
coxsackieviru
human
enteroviru
alteredfidel
variant
describ
date
harbor
mutat
within
viral
rnadepend
rna
polymeras
rdrp
attenu
vivo
protect
reinfect
highlight
potenti
util
live
attenu
vaccin
studi
underscor
import
understand
molecular
mechan
rna
virus
regul
replic
fidel
virus
coronavirina
subfamili
larg
singlestrand
positivesens
rna
genom
ssrna
rang
kb
length
cov
encod
exoribonucleas
exon
ntermin
half
nonstructur
protein
cov
exon
activ
depend
conserv
magnesiumcoordin
acid
amino
acid
three
motif
deed
togeth
constitut
activ
site
fig
cov
exon
group
deddh
superfamili
exonucleas
involv
proofread
prokaryot
eukaryot
dna
replic
alanin
substitut
cov
motif
de
residu
detoaa
reduc
biochem
exon
activ
sarscov
human
coronaviru
sarscov
lack
exon
activ
exon
mutat
frequenc
greater
seen
wt
virus
highli
suscept
activ
nucleosid
analogu
thu
avail
data
date
support
hypothesi
first
known
proofread
enzym
encod
rna
viru
despit
critic
role
exon
viru
replic
fidel
fit
virul
revers
exoninactivit
substitut
fig
detect
follow
passag
cultur
acut
passag
sarscovexon
age
balbc
mice
day
persist
sarscovexon
infect
immunodefici
mice
studi
sought
determin
whether
longterm
passag
passag
year
mhvexon
result
viru
extinct
exon
revers
compens
loss
proofread
demonstr
mhvexon
extinguish
passag
adapt
increas
replic
mhvexon
concurr
evolv
reduc
suscept
multipl
nucleosid
base
analogu
consist
select
increas
replic
fidel
importantli
exoninactiv
substitut
revert
evolv
mutat
mhvexon
encod
rdrp
account
part
increas
nucleosid
analogu
resist
mhvexon
implic
multipl
replicas
protein
adapt
viral
fit
result
studi
support
propos
link
cov
fidel
fit
demonstr
surpris
stabil
exoninactiv
substitut
identifi
addit
protein
outsid
may
contribut
cov
fidel
regul
serial
passag
wtmhv
mhvexon
delay
brain
tumor
dbt
cell
time
viru
passag
harvest
monolay
involv
syncytia
occur
hour
postinfect
hpi
passag
condit
vari
wtmhv
mhvexon
due
differ
replic
kinet
two
virus
stop
passag
observ
reduc
syncytium
format
mhvexon
infect
flask
like
result
mutat
mhvexon
spike
protein
cleavag
site
discuss
mhvexon
signific
replic
defect
rel
wtmhv
first
test
whether
replic
mhvexon
affect
longterm
passag
examin
replic
two
differ
multipl
infect
moi
moi
moi
pfucel
mhvexon
replic
delay
h
peak
titer
reduc
rel
wtmhv
fig
b
consist
previou
studi
two
virus
replic
ident
kinet
fig
b
dot
line
repres
increas
peak
replic
wtmhv
increas
mhvexon
compar
respect
parent
virus
moi
pfucel
also
measur
replic
mhvexon
replic
kinet
gradual
increas
passag
reach
level
fig
determin
whether
increas
replic
mhvexon
affect
presenc
potenti
defect
viral
genom
populationbas
phenomenon
wtmhv
mhvexon
plaqu
purifi
three
time
plaquepurifi
virus
replic
indistinguish
parent
popul
fig
togeth
data
demonstr
wtmhv
mhvexon
popul
adapt
increas
replic
either
individu
genom
deriv
singl
viru
plaqu
encod
adapt
chang
requir
total
popul
determin
whether
increas
replic
mhvexon
result
primari
revers
exon
motif
sequenc
infectedcel
total
rna
mhvexon
retain
motif
detoaa
substitut
demonstr
primari
revers
exon
motif
occur
identifi
potenti
adapt
consensu
mutat
perform
fullgenom
dideoxi
sequenc
mhvexon
wtmhv
within
wtmhv
identifi
mutat
nonsynonym
ns
fig
contrast
mhvexon
total
mutat
ns
fig
fullgenom
sequenc
deposit
genbank
mutat
virus
list
tabl
supplement
materi
identifi
one
mutat
share
virus
though
present
approxim
wtmhv
popul
dideoxi
sequenc
virus
delet
hemagglutinin
esteras
mrna
transcrib
vitro
protein
express
detriment
fit
cell
cultur
wtmhv
also
delet
open
read
frame
dispens
mhv
replic
cell
cultur
ctermin
region
within
mhvexon
truncat
fuse
frameshift
phosphodiesteras
pde
protect
viral
rna
degrad
oligoadenyl
activ
factor
cellular
rnase
l
portion
delet
mhvexon
lie
outsid
pde
catalyt
domain
region
unknown
function
ctermin
truncat
retain
enzymat
activ
whether
specif
delet
fusion
disrupt
pde
activ
remain
test
nevertheless
dispens
mhv
replic
immort
cell
detail
delet
site
provid
fig
supplement
materi
within
protein
predict
part
replicasetranscriptas
complex
nucleocapsid
wtmhv
one
ns
chang
locat
fig
tabl
contrast
mhvexon
ns
chang
within
region
fig
tabl
coronavirus
lack
exon
consist
display
defect
rna
synthesi
rel
wt
strain
determin
whether
increas
replic
mhvexon
associ
restor
genom
rna
grna
product
measur
grna
accumul
time
use
twostep
realtim
quantit
pcr
mhvexon
accumul
level
grna
similar
accumul
wtmhv
wtmhv
earli
time
point
grna
level
mhvexon
lower
fig
mhvexon
grna
level
fell
wtmhv
wtmhv
h
similar
mhvexon
hpi
normal
grna
abund
h
viru
demonstr
rate
grna
accumul
similar
four
virus
fig
data
suggest
increas
replic
virus
rel
wtmhv
fulli
account
increas
rna
synthesi
addit
rna
synthesi
defect
exon
cov
mutat
frequenc
profoundli
increas
sensit
nucleosid
base
analogu
rel
wt
cov
determin
whether
nucleosid
analogu
sensit
mhvexon
alter
longterm
passag
treat
cell
infect
parent
passag
virus
base
analog
convert
intracellularli
nucleosid
analogu
incorpor
grow
rna
strand
caus
g
u
c
mutat
simplic
hereaft
refer
nucleosid
analogu
incorpor
increas
absenc
exon
activ
virus
display
concentrationdepend
decreas
viral
titer
differ
greatli
level
suscept
fig
wtmhv
titer
reduc
mhvexon
titer
undetect
reduct
wtmhv
sensit
alter
passag
mhvexon
less
suscept
mhvexon
treatment
decreas
titer
mhvexon
remain
sensit
wtmhv
suggest
wtlike
resist
requir
intact
exon
data
demonstr
mhvexon
evolv
resist
mutat
outsid
exon
motif
bacteriophag
acquir
resist
delay
cell
lysi
therebi
reduc
number
replic
cycl
incorpor
mhvexon
multipl
mutat
spike
glycoprotein
includ
one
spike
furin
cleavag
site
reduc
syncytium
format
test
whether
spike
mutat
manifest
resist
clone
spike
gene
mhvexon
isogen
mhvexon
background
recombin
viru
demonstr
intermedi
replic
kinet
mhvexon
mhvexon
fig
form
syncytia
also
increas
specif
infect
viral
particl
fig
howev
mhvexon
spike
affect
sensit
recombin
viru
fig
thu
adapt
increas
resist
must
locat
elsewher
genom
date
three
protein
shown
alter
cov
sensit
stimul
exon
activ
neither
wtmhv
mhvexon
contain
ns
mutat
wtmhv
mutat
within
either
contrast
mhvexon
ns
mutat
ns
mutat
fig
none
describ
previous
vitro
viabl
virus
within
six
mutat
predict
rdrp
finger
palm
thumb
domain
fig
four
residu
visual
structur
rdrp
remain
residu
lie
outsid
model
core
rdrp
fig
one
mutat
lie
covspecif
domain
conserv
among
nidovirus
domain
implic
membran
target
perform
essenti
nucleotidyl
activ
arteriviru
equin
arter
viru
howev
predict
catalyz
nucleotidyl
within
ns
mutat
identifi
exon
domain
ns
mutat
ctermin
domain
fig
next
model
structur
mhv
use
softwar
result
highestprob
similar
sarscov
complex
pdb
high
confid
ie
calcul
probabl
true
homolog
structur
residu
model
predict
five
mutat
locat
close
surfac
protein
fig
three
model
zinc
finger
domain
contain
one
ns
mutat
two
mutat
locat
near
interfac
though
neither
site
previous
implic
interact
one
ns
mutat
result
substitut
exon
motif
iii
metalcoordin
activ
site
residu
previous
report
alanin
substitut
result
exon
phenotyp
viabil
phenotyp
substitut
test
studi
data
suggest
network
residu
evolv
regul
activ
stabil
exon
background
determin
approxim
mutat
aros
perform
dideoxi
sequenc
across
proteincod
region
roughli
everi
passag
method
detect
consensu
ns
mutat
fig
carri
full
complement
consensu
mutat
except
minor
variant
maintain
popul
passag
level
correl
increas
replic
mhvexon
fig
decreas
sensit
fig
neither
replic
sensit
mhvexon
chang
substanti
determin
whether
mhvexon
evolv
increas
resist
multipl
nucleosid
analogu
treat
virusinfect
cell
three
addit
analogu
substrat
viral
rdrp
ribavirin
rbv
guanin
analogu
inhibit
viral
replic
multipl
mechan
includ
mutagenesi
inhibit
purin
biosynthesi
azc
rna
mutagen
cmea
propos
incorpor
viral
rna
termin
nascent
transcript
observ
dosedepend
sensit
rbv
azc
cmea
mhvexon
virus
decreas
increas
passag
number
fig
f
except
azc
mhvexon
sensit
chang
togeth
data
demonstr
mhvexon
evolv
increas
resist
multipl
nucleosid
analogu
correl
length
passag
acquisit
mutat
importantli
occur
absenc
specif
mutagen
select
without
revers
exon
motif
increas
gener
select
toward
four
class
nucleotid
strongli
support
idea
overal
increas
fidel
mhvexon
hypothes
mutat
mhvexon
like
impact
replic
nucleosid
analogu
sensit
base
enzymat
activ
tempor
associ
phenotyp
chang
test
hypothesi
engin
recombin
mhvexon
encod
sequenc
alon
togeth
express
alon
combin
alter
replic
kinet
mhvexon
without
affect
peak
titer
fig
increas
grna
level
mhvexon
fig
greater
effect
sensit
mhvexon
analogu
test
combin
increas
resist
seen
alon
fig
e
none
recombin
virus
recapitul
resist
phenotyp
mhvexon
popul
togeth
data
demonstr
mutat
account
partial
nucleosid
analogu
resist
mhvexon
adapt
mask
also
conclud
activ
site
mutat
correct
defect
caus
motif
detoaa
substitut
hypothes
mutat
provid
fit
advantag
mhvexon
compet
recombin
virus
refer
mhvexon
viru
stock
contain
silent
mutat
code
region
mutant
refer
virus
detect
mix
infect
realtim
quantit
pcr
use
dualli
label
probe
specif
viru
mhvexon
show
modest
fit
advantag
refer
mhvexon
silent
strain
fig
solid
green
mhvexon
profoundli
outcompet
mhvexon
silent
mhvexon
genom
present
end
passag
fig
dot
green
line
mhvexon
greater
rel
fit
mhvexon
mhvexon
intermedi
singl
recombin
implic
complex
evolutionari
interact
two
protein
measur
fit
correl
pattern
nucleosid
analogu
resist
rna
synthesi
associ
mutat
suggest
link
evolut
phenotyp
result
also
confirm
import
suffici
account
significantli
increas
fit
mhvexon
rel
mhvexon
although
data
suggest
mhvexon
select
pressur
increas
fidel
detect
primari
revers
detoaa
substitut
mhvexon
passag
test
data
consist
significantli
extend
previou
studi
report
genotyp
stabil
exon
motif
mhv
sarscov
complet
revers
de
within
exon
motif
would
requir
four
nucleotid
chang
like
repres
high
genet
barrier
revers
especi
given
fit
increas
mutat
outsid
fig
singl
doubl
nucleotid
chang
within
motif
could
restor
acid
charg
individu
residu
eg
motif
ea
ad
ed
etc
howev
activ
site
composit
deddh
exonucleas
klenow
fragment
stringent
even
conserv
mutat
e
e
reduc
exon
activ
thu
intermedi
amino
acid
chang
may
select
advantag
compar
motif
aa
limit
evolutionari
pathway
revers
howev
detect
effect
rbv
azc
resist
well
competit
fit
mhvexon
fig
demonstr
modest
capac
fit
adapt
outsid
catalyt
residu
whether
mutat
result
genet
drift
posit
select
remain
unclear
nevertheless
data
show
mhvexon
adapt
increas
fit
without
fulli
restor
exoribonucleas
activ
mutat
mhvexon
like
confer
dbt
cellspecif
select
advantag
other
may
repres
generaliz
strategi
overcom
exon
defect
cell
type
coronavirus
thu
understand
mechan
mhvexon
compens
exon
activ
could
allow
recoveri
exon
variant
cov
transmiss
gastroenter
viru
human
cov
date
nonviabl
exon
recombin
mhvexon
exhibit
increas
resist
four
nucleosid
analogu
passag
fig
although
resist
singl
nucleosid
analogu
evolv
without
increas
overal
fidel
resist
multipl
nucleosid
analogu
strongli
suggest
broadli
increas
capac
discrimin
nucleotid
increasedfidel
variant
rna
virus
frequent
map
rdrp
thu
increas
fidel
contribut
nucleosid
analogu
resist
mhvexon
like
protein
involv
would
three
find
consist
hypothesi
mutat
within
increas
rdrp
fidel
first
nonsynonym
mutat
aros
lowfidel
mhvexon
strain
presenc
proofread
wtmhv
second
five
mutat
lie
near
structur
motif
import
fidel
regul
rdrp
amino
acid
substitut
finger
palm
domain
repeatedli
shown
affect
viral
rdrp
fidel
recent
report
finger
mutat
like
increas
fidel
mhv
rdrp
model
structur
predict
contain
three
mutat
palm
domain
one
finger
domain
thumb
domain
mutat
lie
near
palm
fig
third
exchang
alon
background
mhvexon
reduc
suscept
mhvexon
three
differ
nucleosid
analogu
fig
thu
data
support
hypothesi
highfidel
rdrp
activ
develop
biochem
phenotyp
deep
sequenc
assay
quantifi
fidel
importantli
account
partial
mhvexon
nucleosid
analogu
resist
phenotyp
fig
suggest
possibl
limit
compens
achiev
mutat
rdrp
alon
effect
mutat
addit
may
antagonist
isol
whole
passag
viru
fig
indic
relationship
mutat
like
evolutionarili
link
mhv
protein
fact
substanti
compon
evolv
resist
nucleosid
analogu
explain
presenc
alon
togeth
support
hypothesi
identifi
sever
nonsynonym
mutat
replicas
protein
sarscov
function
interact
act
primaseprocess
factor
helicasentpas
respect
process
factor
herp
simplex
viru
mycobacterium
tuberculosi
regul
dna
polymeras
fidel
balanc
polymeras
extens
exonucleas
activ
helicas
chikungunya
viru
footandmouth
diseas
viru
evolv
increas
fidel
alter
frequenc
ribavirininduc
mutat
respect
sarscov
rnabind
activ
propos
particip
multiprotein
replicas
complex
mhv
uridylatespecif
endoribonucleas
could
plausibl
involv
modul
polymeras
activ
addit
remain
possibl
evolut
increas
fidel
could
involv
protein
outsid
canon
replic
complex
includ
structur
accessori
cassett
thu
immedi
studi
focu
test
whether
replicas
protein
regul
fidel
excit
consid
possibl
virusdirect
discoveri
approach
reveal
novel
interact
multipl
mhv
protein
genom
mutat
rna
virus
commonli
detriment
lethal
one
strategi
prevent
extinct
mutat
load
increas
replic
fidel
discuss
altern
strategi
increas
mutat
robust
mutat
robust
describ
capac
viru
buffer
fit
effect
mutat
set
lowfidel
replic
mhvexon
increas
mutat
robust
could
provid
select
advantag
select
increas
robust
could
explain
synonym
chang
mhvexon
synonym
chang
alter
codon
reduc
probabl
nonconserv
amino
acid
chang
altern
increas
popul
size
mhvexon
could
promot
robust
safetyinnumb
effect
allow
effici
purg
lowfit
mutant
maintain
popul
fit
larg
popul
also
increas
likelihood
coinfect
allow
complement
viral
genom
although
increas
replic
confer
mutat
spike
alter
resist
fig
result
recent
studi
perform
polioviru
suggest
mutagen
popul
elev
coinfect
frequenc
thu
complement
may
contribut
mhvexon
nucleosid
analogu
resist
conflict
evid
exist
regard
whether
mutat
robust
affect
sensit
rna
mutagen
nevertheless
robust
mhvexon
merit
investig
proofread
activ
exoribonucleas
critic
determin
cov
replic
fidel
fit
show
cov
capac
compens
loss
exon
activ
network
mutat
elsewher
genom
thu
appear
play
domin
role
cov
replic
fidel
activ
like
close
tie
highli
evolv
network
protein
demonstr
coadapt
replic
competit
fit
like
increas
fidel
within
mhvexon
support
hypothesi
role
link
function
evolutionarili
interest
test
whether
evolut
cell
type
deriv
differ
speci
differ
innat
immun
environ
would
result
similar
adapt
strategi
genet
biochem
test
rich
mutat
resourc
reveal
mhvexon
like
inform
design
countermeasur
endem
emerg
cov
defin
novel
common
target
stabl
viru
attenu
direct
inhibit
delay
brain
tumor
murin
astrocytoma
clone
cell
maintain
describ
previous
babi
hamster
kidney
bhk
cell
stabli
express
receptor
bhkr
maintain
condit
select
mgml
mediatech
describ
previous
infecti
cdna
clone
recoveri
mhvexon
describ
previous
longterm
passag
initi
infect
subconflu
monolay
cell
flask
either
wildtyp
mhvexon
moi
approxim
pfucel
one
lineag
viru
subject
total
passag
supernat
harvest
passag
store
total
rna
harvest
passag
use
ml
trizol
reagent
ambion
per
flask
store
viru
stock
select
intermedi
passag
gener
infect
subconflu
flask
cell
moi
pfucel
approxim
hpi
flask
frozen
supernat
clarifi
centrifug
g
sorval
plu
rotor
min
viru
titer
stock
determin
plaqu
assay
use
cell
describ
previous
plaqu
assay
virus
contain
spike
protein
mhvexon
form
syncytia
plaqu
visual
neutral
red
sigma
catalog
dilut
phosphatebuff
salin
pb
contain
calcium
magnesium
neutral
red
ad
h
plate
reaction
mixtur
incub
addit
h
formaldehyd
fixat
plaqu
purif
perform
infect
dbt
cell
serial
dilut
viru
overlay
cultur
agar
singl
plaqu
isol
resuspend
pb
contain
calcium
magnesium
inocul
onto
fresh
dbt
process
complet
time
experiment
stock
gener
describ
follow
rna
purifi
harvest
trizol
sampl
accord
manufactur
protocol
revers
transcrib
rt
use
superscript
iii
invitrogen
describ
previous
fullgenom
dideoxi
sequenc
perform
wtmhv
mhvexon
use
overlap
amplicon
approxim
kb
length
code
region
sequenc
fulli
nucleotid
sequenc
viru
wtmhv
mhvexon
two
microlit
rt
product
use
pcr
dideoxi
sequenc
perform
genhunt
corpor
nashvil
tn
genewiz
south
plainfield
nj
sequenc
analysi
perform
use
macvector
version
macvector
inc
apex
nc
infecti
clone
refer
genom
genbank
access
number
nucleotid
sequenc
amplicon
sequenc
primer
avail
upon
request
sequenc
intermedi
passag
perform
use
trizolpurifi
rna
infect
monolay
primer
list
primer
use
gener
nucleotid
amplicon
contain
primer
use
gener
nucleotid
amplicon
contain
pcr
condit
reaction
use
gener
amplicon
use
fullgenom
sequenc
viral
replic
kinet
cell
determin
moi
pfucel
moi
pfucel
describ
previous
supernat
harvest
indic
time
point
viru
titer
determin
plaqu
assay
accumul
genom
rna
moi
pfucel
measur
twostep
realtim
quantit
rtpcr
intracellular
rna
harvest
use
trizol
revers
transcrib
use
superscript
iii
invitrogen
level
cdna
deriv
intracellular
positivesens
viral
rna
measur
use
primer
direct
valu
normal
level
endogen
control
dehydrogenas
gapdh
mutat
within
primer
bind
site
emerg
either
popul
primer
amplif
condit
report
previous
except
rt
product
dilut
prior
use
sampl
plate
technic
duplic
minim
welltowel
variat
data
present
denot
threshold
cycl
ct
valu
target
minu
ct
valu
refer
gapdh
subconflu
monolay
cell
plate
infect
indic
viru
moi
pfucel
supernat
harvest
hpi
level
genom
rna
supernat
measur
use
onestep
realtim
quantit
rtpcr
rtqpcr
trizolextract
rna
describ
previous
briefli
genom
rna
detect
fam
label
black
hole
quencher
label
probe
target
biosearch
technolog
petaluma
ca
rna
copi
number
calcul
refer
rna
standard
deriv
mhv
fragment
sampl
plate
technic
duplic
minim
welltowel
variat
titer
determin
plaqu
assay
cell
specif
infect
calcul
pfu
per
supernat
genom
rna
copi
azc
ribavirin
rbv
purchas
sigma
product
number
respect
stock
solut
prepar
dimethyl
sulfoxid
dmso
cmea
receiv
gilead
scienc
foster
citi
ca
sensit
assay
perform
describ
previous
except
plate
use
moi
pfucel
supernat
harvest
hpi
titer
determin
plaqu
assay
mhv
structur
model
onlin
program
use
residu
correspond
residu
polyprotein
model
analyz
use
pymol
molecular
graphic
system
version
llc
virus
contain
gener
use
revers
genet
system
rna
mhvexon
viru
revers
transcrib
superscript
iii
invitrogen
use
gener
amplicon
contain
either
amplicon
flank
bp
overlap
amplicon
gener
backbon
plasmid
amplicon
insert
fragment
use
infus
hd
clone
kit
takara
bio
usa
inc
mountain
view
ca
split
across
mhv
e
f
contain
within
mhv
f
reaction
mixtur
contain
ng
vector
ng
insert
enzym
incub
min
error
correct
sitedirect
mutagenesi
use
pfu
turbo
polymeras
agil
santa
clara
ca
swap
gener
restrict
digest
individu
swap
use
bsmbi
stui
follow
gel
purif
assembl
use
dna
ligas
neb
ipswich
viabl
virus
construct
rescu
describ
previous
competitor
virus
compet
mhvexon
viru
harbor
silent
mutat
probebind
region
within
subconflu
monolay
plate
coinfect
total
moi
pfucel
competitor
refer
virus
ratio
passag
time
passag
supernat
harvest
h
rna
extract
supernat
use
trizol
reagent
purelink
rna
minikit
column
thermo
scientif
waltham
supernat
use
infect
fresh
cell
plate
total
moi
estim
pfucel
proport
viru
determin
realtim
rtqpcr
infect
supernat
use
two
taqman
probe
differ
fluoresc
dye
separ
reaction
competitor
virus
detect
probe
use
specif
infect
analys
refer
virus
detect
probe
target
region
silent
mutat
label
quasar
black
hole
quencher
biosearch
technolog
petaluma
ca
rna
copi
number
calcul
refer
rna
standard
gener
vitro
transcript
correspond
mhv
fragment
rel
rna
abund
calcul
ratio
competitor
genom
refer
genom
graphpad
prism
la
jolla
ca
use
perform
statist
test
comparison
shown
statist
signific
indic
ns
nonsignific
asterisk
within
figur
describ
legend
perform
mani
case
data
normal
result
obtain
untreat
control
perform
use
graphpad
prism
number
replic
sampl
denot
within
figur
legend
fulllength
genom
sequenc
wtmhv
mhvexon
deposit
genbank
access
number
respect
